Wisdomtree Biorevolution Etf Performance
| WDNA Etf | USD 15.11 0.07 0.46% |
The entity maintains a market beta of 0.46, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, WisdomTree BioRevolution's returns are expected to increase less than the market. However, during the bear market, the loss of holding WisdomTree BioRevolution is expected to be smaller as well.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days WisdomTree BioRevolution has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, WisdomTree BioRevolution is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors. ...more
1 | Explore our list of Exchange Traded Funds for 2025 - The Armchair Trader | 11/29/2024 |
| In Threey Sharp Ratio | -0.73 |
WisdomTree |
WisdomTree BioRevolution Relative Risk vs. Return Landscape
If you would invest 1,577 in WisdomTree BioRevolution on October 26, 2024 and sell it today you would lose (59.00) from holding WisdomTree BioRevolution or give up 3.74% of portfolio value over 90 days. WisdomTree BioRevolution is currently does not generate positive expected returns and assumes 1.4347% risk (volatility on return distribution) over the 90 days horizon. In different words, 12% of etfs are less volatile than WisdomTree, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
WisdomTree BioRevolution Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for WisdomTree BioRevolution's investment risk. Standard deviation is the most common way to measure market volatility of etfs, such as WisdomTree BioRevolution, and traders can use it to determine the average amount a WisdomTree BioRevolution's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0379
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | WDNA |
Estimated Market Risk
| 1.43 actual daily | 12 88% of assets are more volatile |
Expected Return
| -0.05 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.04 actual daily | 0 Most of other assets perform better |
Based on monthly moving average WisdomTree BioRevolution is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of WisdomTree BioRevolution by adding WisdomTree BioRevolution to a well-diversified portfolio.
WisdomTree BioRevolution Fundamentals Growth
WisdomTree Etf prices reflect investors' perceptions of the future prospects and financial health of WisdomTree BioRevolution, and WisdomTree BioRevolution fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on WisdomTree Etf performance.
| Total Asset | 4.54 M | |||
About WisdomTree BioRevolution Performance
By analyzing WisdomTree BioRevolution's fundamental ratios, stakeholders can gain valuable insights into WisdomTree BioRevolution's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if WisdomTree BioRevolution has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if WisdomTree BioRevolution has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
The fund generally uses a representative sampling strategy to achieve its investment objective, meaning it generally will invest in a sample of the securities in the index whose risk, return and other characteristics resemble the risk, return and other characteristics of the Index as a whole. Wisdomtree Biorevolution is traded on BATS Exchange in the United States.| WisdomTree BioRevolution generated a negative expected return over the last 90 days | |
| The fund created three year return of -8.0% | |
| WisdomTree BioRevolution keeps all of its net assets in stocks |
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in WisdomTree BioRevolution. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
The market value of WisdomTree BioRevolution is measured differently than its book value, which is the value of WisdomTree that is recorded on the company's balance sheet. Investors also form their own opinion of WisdomTree BioRevolution's value that differs from its market value or its book value, called intrinsic value, which is WisdomTree BioRevolution's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because WisdomTree BioRevolution's market value can be influenced by many factors that don't directly affect WisdomTree BioRevolution's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between WisdomTree BioRevolution's value and its price as these two are different measures arrived at by different means. Investors typically determine if WisdomTree BioRevolution is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, WisdomTree BioRevolution's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.